UNPKG

@medplum/fhirtypes

Version:

Medplum FHIR Type Definitions

97 lines (86 loc) 3.71 kB
/* * This is a generated file * Do not edit manually. */ import { CodeableConcept } from './CodeableConcept'; import { Extension } from './Extension'; import { Period } from './Period'; /** * The marketing status describes the date when a medicinal product is * actually put on the market or the date as of which it is no longer * available. */ export interface MarketingStatus { /** * Unique id for the element within a resource (for internal references). * This may be any string value that does not contain spaces. */ id?: string; /** * May be used to represent additional information that is not part of * the basic definition of the element. To make the use of extensions * safe and manageable, there is a strict set of governance applied to * the definition and use of extensions. Though any implementer can * define an extension, there is a set of requirements that SHALL be met * as part of the definition of the extension. */ extension?: Extension[]; /** * May be used to represent additional information that is not part of * the basic definition of the element and that modifies the * understanding of the element in which it is contained and/or the * understanding of the containing element's descendants. Usually * modifier elements provide negation or qualification. To make the use * of extensions safe and manageable, there is a strict set of governance * applied to the definition and use of extensions. Though any * implementer can define an extension, there is a set of requirements * that SHALL be met as part of the definition of the extension. * Applications processing a resource are required to check for modifier * extensions. * * Modifier extensions SHALL NOT change the meaning of any elements on * Resource or DomainResource (including cannot change the meaning of * modifierExtension itself). */ modifierExtension?: Extension[]; /** * The country in which the marketing authorisation has been granted * shall be specified It should be specified using the ISO 3166 ‑ 1 * alpha-2 code elements. */ country: CodeableConcept; /** * Where a Medicines Regulatory Agency has granted a marketing * authorisation for which specific provisions within a jurisdiction * apply, the jurisdiction can be specified using an appropriate * controlled terminology The controlled term and the controlled term * identifier shall be specified. */ jurisdiction?: CodeableConcept; /** * This attribute provides information on the status of the marketing of * the medicinal product See ISO/TS 20443 for more information and * examples. */ status: CodeableConcept; /** * The date when the Medicinal Product is placed on the market by the * Marketing Authorisation Holder (or where applicable, the * manufacturer/distributor) in a country and/or jurisdiction shall be * provided A complete date consisting of day, month and year shall be * specified using the ISO 8601 date format NOTE “Placed on the market” * refers to the release of the Medicinal Product into the distribution * chain. */ dateRange: Period; /** * The date when the Medicinal Product is placed on the market by the * Marketing Authorisation Holder (or where applicable, the * manufacturer/distributor) in a country and/or jurisdiction shall be * provided A complete date consisting of day, month and year shall be * specified using the ISO 8601 date format NOTE “Placed on the market” * refers to the release of the Medicinal Product into the distribution * chain. */ restoreDate?: string; }